Vertex: NHS England will have to do better with CF drugs offer by Eric Sagonowsky Tuesday, July 17, 2018 England’s National Health Service made its "final" offer to cover Vertex's cystic fibrosis drugs, but the company still isn't happy.
Patients wait as Vertex, U.K. officials argue over Orkambi price by Eric Sagonowsky Monday, July 9, 2018 Vertex CEO Jeffrey Leiden took his fight over CF drug prices to U.K. Prime Minister Theresa May, urging her to step in.
Vertex cancels plans for CF triple combo testing in France by Eric Sagonowsky Thursday, February 15, 2018 Vertex has cancelled plans to test an investigational triple combo at several sites in France.
Vertex could do M&A large and small, CEO says at JPM by Eric Sagonowsky Monday, January 8, 2018 Vertex is ready to do some deals, CEO Jeffrey Leiden said Monday, and he's shopping beyond cystic fibrosis. CRISPR, for instance.
Analysts peg Vertex and Alexion as stalwarts in tough 2018 by Arlene Weintraub Tuesday, January 2, 2018 Stepped-up competition and insurer pushback aren't going away, but some are better able to handle it—and could emerge as top M&A targets.
Vertex wins once-rejected Kalydeco label expansion by Carly Helfand Friday, May 19, 2017 Last year, the FDA nixed Vertex’s bid to expand Kalydeco to patients with specific mutations in the CFTR gene. On Wednesday, though, the drugmaker finally got what it wanted.
Vertex CEO Leiden’s pay plummets 40% by Arlene Weintraub Tuesday, April 18, 2017 Vertex started tying compensation more closely to company performance last year, and it showed in CEO Jeff Leiden's 2016 pay.
Vertex trumpets data for new CF combo it hopes can outdo sluggish Orkambi by Carly Helfand Thursday, March 30, 2017 Vertex has a new cystic fibrosis combo prospect it hopes can fare better than Orkambi—but the question is, how much?
Vertex to shutter Canada site, focus in on 3 hubs in R&D shuffle by Eric Sagonowsky Tuesday, March 28, 2017 Vertex is consolidating its R&D operations to three sites and shuttering one facility in Canada in a move that will claim 70 jobs there.
